Abstract
Elevated whole blood serotonin (WB5-HT) is a well-replicated biomarker in autism spectrum disorder (ASD). Decreased platelet serotonin receptor 5-HT2A binding has been reported in ASD. WB5-HT levels and platelet 5-HT2A specific binding were obtained from 110 individuals with ASD and 18 controls. Individuals with ASD had significantly higher WB5-HT levels than controls. There was no difference in the platelet 5-HT2A specific binding between groups. Multiple regression analyses revealed that platelet 5-HT2A binding significantly predicted WB5-HT in the control sample but not in the ASD sample. These results indicate that the relationship between WB5-HT and platelet 5-HT2A binding differs depending on ASD diagnosis, suggesting differences in platelet 5-HT system regulation in ASD.
Original language | English (US) |
---|---|
Pages (from-to) | 2417-2425 |
Number of pages | 9 |
Journal | Journal of Autism and Developmental Disorders |
Volume | 49 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2019 |
Bibliographical note
Publisher Copyright:© Springer Science+Business Media, LLC, part of Springer Nature 2019.
Keywords
- Autism spectrum disorder
- Biomarker
- Hyperserotonemia
- Receptor
- Serotonin